biotech · PPCB
Propanc Biopharma
Propanc Biopharma patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- CAMBERWELL, VICTORIA, C3, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 3
Propanc Biopharma patents
3 pharmaceutical patents indexed for Propanc Biopharma. 0 expire within 24 months.
Propanc Biopharma has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12419938
Proenzyme composition
granted -
US 11376313
Cancer treatment
granted -
US 10350239
Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
granted
Frequently asked questions
How many patents does Propanc Biopharma have?
3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Propanc Biopharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.